Construction has begun on the region’s first proton therapy center at the Huntsman Cancer Institute (HCI) at the University of Utah. Being built at the south end of the HCI Cancer Hospital, the center will be named in honor of U.S. Sen. Orrin G. Hatch.
The $31 million, 7,450-square-foot addition at the HCI campus will be the first proton therapy center in the Intermountain West. Proton therapy is a type of radiation therapy for cancer that delivers beams of radiation to shrink a tumor. Approximately half of all cancer patients receive some type of radiation therapy as part of their cancer treatment. Proton therapy delivers a specialized type of radiation and is the favored approach for many tumors in and around vital structures, such as the spinal cord and brain stem. It is also the preferred treatment for certain childhood cancers.
The naming of the center was provided by a $10 million gift from the Huntsman Cancer Foundation (HCF).
“Sen. Hatch has been a steadfast supporter of Huntsman Cancer Institute since Day One,” said Peter Huntsman, chairman and CEO of HCF. “Sen. Hatch’s support completely changed the landscape for cancer care in our region. Thus, we think it is most fitting to name in his honor this new center that will provide a critical new resource to patients in our region.” Zions Bank also provided a contribution to the naming of the center.
Currently, the proton therapy centers nearest to Salt Lake City are located in southern Arizona and southern California, approximately a 10-hour drive away. Patients who are given proton therapy may need a treatment course that occurs five days a week and spans four to eight weeks.
“This new treatment space is essential to HCI’s continuing commitment to serve cancer patients and provide them access to the most state-of-the-art care,” said HCI CEO Mary Beckerle. “As we take this major step forward for cancer patients in the region, we also reflect on the incredible commitment of people like the Huntsman family and Sen. Hatch who have been dedicated advocates for people affected by cancer.”
The center will provide an opportunity for Utah to participate in advancing research and training related to radiation therapy. “We are grateful for the decades of support Sen. Hatch has provided to cancer research and care and are enthusiastic about innovative treatments made possible in this facility,” said Ruth Watkins, UofU president.
The center is projected to serve up to 200 patients a year when it is fully operational, HCI said in a release.
“The Senator Orrin G. Hatch Center for Proton Therapy will augment the therapies already available at HCI and provide the newest radiation technology to patients from Utah and the surrounding region, many of whom now travel out-of-state to receive this treatment,” said Dr. Dennis Shrieve, HCI radiation oncologist and professor and chair of radiation oncology at the university. It is anticipated to begin treating patients in fall 2020.